C07D 333/58
Radicals substituted by nitrogen atoms
C07D333/58 (Radicals substituted by nitrogen atoms) appears on 317 US grants and 254 published applications in this corpus.
Search patents in C07D- Granted patents
- 317
- Published applications
- 254
- Assignees
- 201
- Inventors
- 1,157
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 1 | 0 |
| 1981 | 5 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 6 | 0 |
| 1988 | 6 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 6 | 0 |
| 1992 | 7 | 0 |
| 1993 | 9 | 0 |
| 1994 | 10 | 0 |
| 1995 | 8 | 0 |
| 1996 | 10 | 0 |
| 1997 | 12 | 0 |
| 1998 | 9 | 0 |
| 1999 | 6 | 0 |
| 2000 | 6 | 0 |
| 2001 | 12 | 1 |
| 2002 | 4 | 5 |
| 2003 | 11 | 8 |
| 2004 | 2 | 23 |
| 2005 | 4 | 15 |
| 2006 | 5 | 23 |
| 2007 | 12 | 17 |
| 2008 | 12 | 16 |
| 2009 | 14 | 27 |
| 2010 | 13 | 13 |
| 2011 | 16 | 9 |
| 2012 | 12 | 10 |
| 2013 | 6 | 7 |
| 2014 | 6 | 6 |
| 2015 | 5 | 4 |
| 2016 | 7 | 5 |
| 2017 | 4 | 5 |
| 2018 | 5 | 3 |
| 2019 | 6 | 6 |
| 2020 | 8 | 8 |
| 2021 | 1 | 6 |
| 2022 | 4 | 7 |
| 2023 | 5 | 9 |
| 2024 | 7 | 8 |
| 2025 | 8 | 7 |
| 2026 | 3 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Small molecules with antibacterial activity16 Jun 2026US 12,655,101 B2New Mexico Tech University Research Park Corporation
- Organic electroluminescence device and electronic apparatus provided with the same28 Apr 2026US 12,615,959 B2Idemitsu Kosan Co., Ltd.
- Oral complement factor D inhibitors24 Feb 2026US 12,558,341 B2BioCryst Pharmaceuticals, Inc.
- Advantageous benzothiophene compositions for mental disorders or enhancement4 Nov 2025US 12,459,912 B2Tactogen Inc
- 7-methyl indole analogs and dosage forms containing the same14 Oct 2025US 12,441,683 B2Kuleon LLC
- Thienyl compounds for the treatment of a central nervous system disease or disorder17 Sep 2026US 2026/0274814 A1
- Treatment of signs, symptoms and/or complications of viral, bacterial, protozoal, and/or fungal infections by high penetration prodrugs27 Aug 2026US 2026/0248922 A1Techfields Inc.
- N-phenyl-3-(2,5-dioxopyrrolidin-1-yl)propanamide derivatives and similar compounds as dux4 inhibitors for the treatment of e.g. neuromuscular disorders25 Jun 2026US 2026/0176256 A1Altay Therapeutics, Inc.
- Oral complement factor d inhibitors18 Jun 2026US 2026/0165999 A1BioCryst Pharmaceuticals, Inc.
- Small molecule direct inhibitors of keap1-nrf2 protein-protein interaction11 Jun 2026US 2026/0158027 A1Rutgers, The State University of New Jersey
Most cited
By later US patents
- Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them565US 5,514,718 AMerck Sharp & Dohme Corp. · 1996
- Catecholamine surrogates useful as .beta..sub.3 agonists122US 5,776,983 ABristol-Myers Squibb Company · 1998
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds108US 4,873,259 AAbbott Laboratories · 1989
- Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents94US 7,157,491 B2Wyeth · 2007